| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 6,734 | 8,360 | | Cost of Revenue | 3,051 | 3,518 | | | Gross Profit | 3,683 | 4,842 | | | Operating Expenses | | Research Development | 3,040 | 7,424 | | Selling General and Administrative | 6,434 | 6,087 | | Non Recurring | 9,978 |
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (15,769) | (8,669) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,838 | 767 | | Earnings Before Interest And Taxes | (9,931) | (7,902) | | Interest Expense | 203 | 862 | | Income Before Tax | (10,134) | (8,764) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (10,134) | (8,764) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (10,134) | (8,764) | | Preferred Stock And Other Adjustments |
-
| (9,790) | | | Net Income Applicable To Common Shares | ($10,134) | ($18,554) |
|
0.26% Nasdaq 0.00%
Income Statement
